NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.360
+0.080 (6.25%)
At close: Dec 20, 2024, 4:00 PM
1.350
-0.010 (-0.74%)
After-hours: Dec 20, 2024, 6:51 PM EST
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $26.48 million as of December 20, 2024. Its market cap has increased by 143.43% in one year.
Market Cap
26.48M
Enterprise Value
26.16M
1-Year Change
143.43%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $26.48M, a decrease of -59.02%. That is a compound annual growth rate of -25.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 26.48M | 146.84% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HOOKIPA Pharma | 25.80M |
| Cognition Therapeutics | 25.52M |
| Lipocine | 25.44M |
| Femasys | 25.20M |
| Pluri | 25.18M |
| PolyPid | 25.04M |
| Daré Bioscience | 24.97M |
| Calidi Biotherapeutics | 24.92M |